Medical Dynamics

House Passes Plan to Stop Medicare Cuts to Doctors

J&J Plant Involved in Recall to Stay Closed

P&G Recalls Nasal Spray Sold in U.S. Stores

Kowa’s US CEO Says New Statin Holds Appeal for Untreated Patients

Native Americans Embrace Tradition to Defeat Diabetes

Read the rest of this entry »

Obesity Task Force Urges Action

U.S. Group Urges FDA to Halt Glaxo’s Avandia Trial

Health Overhaul Law Potentially Costs $115B More

First Lady Releases Child Obesity Recommendations

Merck: Schering-Plough Integration is on Track

How’s My Detailing? Dial 1-877-RX-DDMAC

Consumers Want Unbranded Sites, Despite FDA Warnings

Colin Powell and Bill Gates Join Malaria Campaign

Merck Inks Deal on Tetanus, Diphtheria Vaccine

Abbott First-Quarter Profit Falls as Costs Increase

Senate Bill Sets a Plan to Regulate Premiums

Drug Maker Elan Narrows Loss

Read the rest of this entry »

Changing Old Habits Could Save Big On Drug Costs

Biogen First-Quarter Profit Drops on Higher Research

J&J First-Quarter Profit Rises on Device Sales Gains

Benefit for Uninsured May Still Pose Hurdle

Cancer Fight: Unclear Tests for New Drug

Read the rest of this entry »

Mixed Reviews For New Parkinson’s Drug (VisitBulgaria)
Ethicon Endo-Surgery launch one-handed articulating endocutter (MTBEurope.info)
Pfizer Won’t Share Wyeth’s Q3 Numbers; Layoff Announcements Due This Week (Industry.bnet.com)

Read the rest of this entry »

Eli Lilly Swings To 3Q Profit Amid Year-Ago Zyprexa Charge (Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Pfizer earnings up 26% despite lower sales of many drugs (Pharma Times)

Biogen profits leap as Tysabri sales soar again (Pharma Times)

Read the rest of this entry »